2021
Persistent Postoperative Vasoplegia After Ureteronephrectomy Due To Suspected Intravesical Gemcitabine Toxicity
Yan L, Bohorquez MA, Carr ZJ. Persistent Postoperative Vasoplegia After Ureteronephrectomy Due To Suspected Intravesical Gemcitabine Toxicity. A&A Practice 2021, 15: e01537. PMID: 34695040, DOI: 10.1213/xaa.0000000000001537.Peer-Reviewed Case Reports and Technical NotesConceptsIntravesical adjuvant therapyPulmonary embolic phenomenaTreatment of patientsPotential adverse eventsPostoperative vasoplegiaRobotic nephroureterectomyVasopressor supportAdjuvant therapyPostoperative courseAdverse eventsEmbolic phenomenaSupportive managementResuscitative effortsAllergic reactionsCommon causeVasoplegiaGemcitabine toxicityGemcitabinePatientsUreteronephrectomyNephroureterectomyBleedingTherapyInfectionEndocrine emergencies in anesthesia
Fernandez-Robles C, Carr ZJ, Oprea AD. Endocrine emergencies in anesthesia. Current Opinion In Anaesthesiology 2021, 34: 326-334. PMID: 33935181, DOI: 10.1097/aco.0000000000000986.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsEndocrine disordersPerioperative managementOral hyperglycemic agentsPerioperative fluid resuscitationPerioperative glycemic managementSafe perioperative managementCommon endocrine disorderPerioperative time periodNumber of patientsBetter operative outcomesInvasive surgical techniquesCarcinoid syndromeEndocrine emergencyAdverse eventsFluid resuscitationGlycemic managementOperative outcomesAvoidable complicationsMedical managementComplex patientsSurgical techniqueHyperglycemic agentOptimal managementOperating roomDisorders
2018
Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single-center retrospective analysis
Karamchandani K, Schoaps RS, Bonavia A, Prasad A, Quintili A, Lehman EB, Carr ZJ. Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single-center retrospective analysis. Therapeutic Advances In Drug Safety 2018, 10: 2042098618809933. PMID: 31019677, PMCID: PMC6463330, DOI: 10.1177/2042098618809933.Peer-Reviewed Original ResearchIntensive care unitAtypical antipsychoticsHospital dischargeMale sexRisk factorsSingle-center retrospective chart analysisSingle-center retrospective analysisTertiary care academic medical centerAdult intensive care unitsRisk of continuationSignificant adverse eventsRetrospective chart analysisAssociated risk factorsIntensive care settingAtypical antipsychotic medicationsYears of ageAcademic medical centerLong-term riskLong-term useAAP therapyCause mortalityAdult patientsAdverse eventsOlder patientsICU patients